Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / COM
-
Number of holders
-
83
-
Total 13F shares, excl. options
-
33.5M
-
Shares change
-
+2.09M
-
Total reported value, excl. options
-
$239M
-
Value change
-
+$16.2M
-
Put/Call ratio
-
0.8
-
Number of buys
-
41
-
Number of sells
-
-28
-
Price
-
$7.16
Significant Holders of AVADEL PHARMACEUTICALS - COM (AVDL) as of Q4 2022
104 filings reported holding AVDL - AVADEL PHARMACEUTICALS - COM as of Q4 2022.
AVADEL PHARMACEUTICALS - COM (AVDL) has 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33.5M shares
.
Largest 10 shareholders include RTW INVESTMENTS, LP (5.74M shares), GENDELL JEFFREY L (5.12M shares), COWEN AND COMPANY, LLC (3.73M shares), Polar Capital Holdings Plc (2.81M shares), Vivo Capital, LLC (2.75M shares), WEALTH EFFECTS LLC (2.51M shares), BRANDES INVESTMENT PARTNERS, LP (1.66M shares), JANUS HENDERSON GROUP PLC (1.21M shares), RENAISSANCE TECHNOLOGIES LLC (686K shares), and Tri Locum Partners LP (685K shares).
This table shows the top 83 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.